top
Search terms
Results 1 - 10 of 12 - ordered by :
Pages: 1 2
Ehjcvp

Given the burden of cardiovascular disease in patients with diabetes, the focus should shift towards cardiovascular outcome studies designed to evaluate efficacy (i.e. to determine the efficacy of a ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEWS, Faiez Zannad, Wendy Gattis Stough, Raymond J. Lipicky, Juan Tamargo, George L. Bakris, Jeffrey S. Borer, Maria de los Angeles Alonso ...

Date : 01/07/2016 Item size : 285307 bytes
Ehjournal

Download the Issue @ a Glance podcast Subscribe to the EHJ Podcast The evaluation of patients presenting to the emergency department with suspected acute coronary syndrome remains a clinical ...

European Heart Journal, ISSUE @ A GLANCE, Thomas F. Lüscher

Date : 07/08/2016 Item size : 193888 bytes
Ehjournal

Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors are a new class of drugs able to decrease LDL-C by 5070% when administered either as a monotherapy or on a background with statins.46 ...

European Heart Journal, ISSUE @ A GLANCE, Thomas F. Lüscher

Date : 21/09/2015
Ehjournal

Introduction Type 2 diabetes increases the risk of cardiovascular mortality by a factor of 1.5 to 4.13Patients with both diabetes and prior cardiovascular disease have a particularly poor ...

European Heart Journal, Becker, Annemarie, Bos, Griët, de Vegt, Femmie, Kostense, Piet J, Dekker, Jacqueline M, Nijpels, Giel, Heine, Robert J, Bouter, Lex M, Stehouwer, Coen D.A

Date : 01/08/2003
Ehjournal

After diagnostic evaluation, only 1525% of patients with chest pain are found to have an acute coronary artery syndrome (ACS).1,2 Improved strategies for stress testing, myocardial imaging, and the ...

European Heart Journal, Pitt, Bertram

Date : 01/03/2012
Ehjournal

Introduction Type 2 diabetes increases the risk of cardiovascular mortality by a factor of 1.5 to 4.13Patients with both diabetes and prior cardiovascular disease have a particularly poor ...

European Heart Journal, Becker, Annemarie, Bos, Griët, de Vegt, Femmie, Kostense, Piet J, Dekker, Jacqueline M, Nijpels, Giel, Heine, Robert J, Bouter, Lex M, Stehouwer, Coen D.A

Date : 01/08/2003 Item size : 183859 bytes
Ehjournal

Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors are a new class of drugs able to decrease LDL-C by 5070% when administered either as a monotherapy or on a background with statins.46 ...

European Heart Journal, Lüscher, Thomas F.

Date : 21/09/2015
Ehjournal

Screening for cardiovascular disease using B-type natriuretic peptides: detecting an imbalance of the four humoursThe opinions expressed in this article are not necessarily those of the Editors of ...

European Heart Journal, Markham, David W., de Lemos, James A.

Date : 01/11/2005 Item size : 98460 bytes
Ehjournal

Screening for cardiovascular disease using B-type natriuretic peptides: detecting an imbalance of the four humoursThe opinions expressed in this article are not necessarily those of the Editors of ...

European Heart Journal, Markham, David W., de Lemos, James A.

Date : 01/11/2005 Item size : 98383 bytes
Ehjournal

After diagnostic evaluation, only 1525% of patients with chest pain are found to have an acute coronary artery syndrome (ACS).1,2 Improved strategies for stress testing, myocardial imaging, and the ...

European Heart Journal, Pitt, Bertram

Date : 01/03/2012 Item size : 124749 bytes